Literature DB >> 837754

The present status of treatment of pulmonary sarcoidosis: a house divided.

R A DeRemee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 837754     DOI： 10.1378/chest.71.3.388

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  9 in total

1.  Glucocorticosteroids and pulmonary sarcoidosis.

Authors:  O Selroos
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

2.  British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.

Authors:  G J Gibson; R J Prescott; M F Muers; W G Middleton; D N Mitchell; C K Connolly; B D Harrison
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

3.  Suppression of the alveolitis in pulmonary sarcoidosis by oral corticosteroids.

Authors:  G A Rossi; G B Di Negro; E Balzano; E Cerri; O Sacco; B Balbi; A Venturini; R Ramoino; C Ravazzoni
Journal:  Lung       Date:  1985       Impact factor: 2.584

4.  67Ga scintigraphy as an index of disease activity in pulmonary sarcoidosis.

Authors:  C Alberts; J B van der Schoot; A S Groen
Journal:  Eur J Nucl Med       Date:  1981

5.  Semi-quantitative gallium-67 lung scanning as a measure of the intensity of alveolitis in pulmonary sarcoidosis.

Authors:  G J Duffy; K Thirumurthi; M Casey; F Barker; N Brennan; C Odlum; M X Fitzgerald
Journal:  Eur J Nucl Med       Date:  1986

6.  Systemic immune response of patients with active pulmonary sarcoidosis.

Authors:  R P Baughman; P E Hurtubise
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

7.  Sarcoidosis: a clinical, roentagenographic and pathological survey.

Authors:  V J Nessan; J Malin; S D Parks
Journal:  West J Med       Date:  1981-11

Review 8.  Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis.

Authors:  Robina K Coker
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Management strategies for pulmonary sarcoidosis.

Authors:  Robina Kate Coker
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.